Skip to content

2027 ASKP3 Annual Conference Call for Abstracts

11.Call For Abstract Primary Presenter

Thank you for your interest in submitting an abstract for consideration as a presentation at the 2027 ASKP3 Annual Conference on January 28-30, in Austin, TX. Please note, we have a new addition and opportunity added for this year's submission process.

The ASKP3 Annual Conference is designed to provide a variety of educational topics that will advance the safe and ethical use of ketamine to treat mental health disorders and pain conditions.

In order to be considered, please complete your submission no later than 11:59 p.m. ET on Monday, June 15, 2026.

Submissions will be reviewed only if all required components are submitted before the submission close date.

Please ensure that all co-presenter information—including full contact details, professional designations, CVs, headshots, and bios—is submitted along with your abstract proposal to complete the submission process.

**New Opportunity for 2027: ASKP3 is creating an Annual Conference Abstract Book with Digital Object Identifier (DOI) references. DOI publication is a permanent, citable link that allows the work to be reliably located and referenced overtime. This initiative will strengthen the academic and professional value of submissions; creating a visible body of work to inform education, advocacy and policy discussions in the field.

You may opt-in and provide additional details for your submission to be considered for the Digital Annual Conference Abstract Book. Or you may opt-out and use your abstract submission for presentation at the Annual Conference only.

Please contact ASKP3 Headquarters by emailing info@askp.org with any questions.

Thank you for your submission and interest!
1.Primary Presenter Full Name (include designations)(Required.)
2.Primary Presenter Organization Name(Required.)
3.Primary Presenter Title(Required.)
4.Primary Presenter Email(Required.)
5.Primary Presenter Phone (best phone number for ASKP3 to reach you with any questions on your submission).(Required.)
6.Target Audience (Check all that apply.)(Required.)
7.Type of Presentation(Required.)
8.Presentation Title (100 character limit)(Required.)
9.Brief description (100 word limit)(Required.)
10.Link to publication (if data is published)
11.Please list three (3) measurable learning objectives for your proposed session.

Your learning objectives should clearly describe what participants will be able to do after attending your session. Objectives must be written using action verbs that reflect observable and measurable outcomes.

Avoid vague terms like “understand” or “learn” and instead use specific, action verbs such as:

Identify
Describe
Demonstrate
Apply
Evaluate
Compare
Analyze

Example: "Evaluate the clinical protocols and safety considerations involved in the implementation of ketamine infusion therapy for treatment-resistant depression."(Required.)
12.Abstract Summary (500-word limit)(Required.)
13.Primary Presenter CV/Resume(Required.)
No file chosen
14.Primary Presenter Headshot(Required.)
No file chosen
15.Brief Primary Presenter Introduction Bio: Please provide a short introduction of the primary presenter (in third person) for credit approval and for use by the session moderator (LIMITED TO 150 CHARACTERS). Highlight your work and industry-related experience.(Required.)
16.Do you have co-presenters? (Please note Co-Presenter information MUST be completed before you submit your abstract)(Required.)
73%